Rankings
▼
Calendar
ACRS Q2 2017 Earnings — Aclaris Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ACRS
Aclaris Therapeutics, Inc.
$407M
Q2 2017 Earnings
Healthcare
Medical - Diagnostics & Research
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$15M
Net Income
-$15M
EPS (Diluted)
$-0.56
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$10M
Free Cash Flow
-$10M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$177M
Total Liabilities
$9M
Stockholders' Equity
$168M
Cash & Equivalents
$33M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$15M
-$13M
-17.8%
Net Income
-$15M
-$13M
-15.3%
← FY 2017
All Quarters
Q3 2017 →